Will Pakistan ever become polio free?
By Naseem Salahuddin and Laila Rizvi
In Pakistan, polio cases have decreased by over 99pc since 1988, from an estimated 350,000 cases then, to 54 in 2015, and 19 reported in 2016.
With the last population census conducted in 1998, the hurdles in estimating the number of children requiring vaccinations are significant.
Oftentimes, while walking through the streets of Pakistan’s cities, small towns or villages, one comes across a man or woman dragging a limp leg or foot, or a shrunken arm hanging loosely by the side.
Some are permanently incapacitated; others may have struggled through a lifetime of trials and tribulations to attain a place in society.
Their untold challenges have taken up a new perspective ever since Pakistan attained the dubious distinction of being the last bastion of the poliovirus.
In Pakistan, polio cases have decreased by over 99pc since 1988, from an estimated 350,000 cases then, to 54 in 2015, and 19 reported in 2016.
However, Pakistan’s polio eradication programme has come under international scrutiny given its position as the main driver for curtailing the global wild poliovirus spread in recent years.
Being one of the biggest partnerships at the global level, the polio eradication initiative faces several challenges on the ground.
Most importantly, the last population census was conducted 19 years ago; hence there are continuous and significant hurdles in estimating the number of children requiring vaccinations.
This affects proper planning and resource allocation for immunisation activities. If there are no proper targets, then, it becomes impossible to assess whether the reported coverage reflects the actual number of children needed to be reached in a geographic area.
To add, financial and organisational deficits, as well as conflict and insecurity have contributed to the persistent failure of immunisation campaigns countrywide.
Poliovirus causes disease only in humans, and affects vulnerable children. It spreads person to person via fingers carrying contaminated faeces. Once it enters the body, it multiplies inside the gut.
Two to three weeks later, the child gets a fever, headache, sore throat, vomiting and abdominal pain — symptoms that resemble a nonspecific acute viral infection.
The diagnosis may go unrecognised, or it can be made precisely if specimens are sent to a special laboratory for isolation of the virus from the throat or faeces, or through a specific blood test.
This is normally not required, as 95pc of children recover completely within a week or two, and there may not be need to confirm a diagnosis of what seems like an innocuous self-limiting viral infection.
The recovered child, however, continues to excrete the virus from the throat and in the stool for at least several weeks to months, and can infect food and water in unsanitary conditions, thus perpetuating the infection.
Five per cent of children, however, do not recover; rather, they progress to viral meningitis, and may recover slowly.
The unfortunate 0.1pc of all polio victims develop paralysis over one to two days, affecting different groups of limb muscles. The paralysis is irreversible, and the child grows into adulthood with permanent loss of limb function.
Others may suffer even more severe involvement of the nervous system, and can die from polio.
Historically, polio has been known to cause outbreaks in many countries, resulting in disability among children and young adults.
Treatment modalities were mainly anecdotal, ranging from herbs and serums to hydrotherapy and physiotherapy to kill pain, and even placing critically ill patients in the Iron Lung for months to years to help them breathe.
Obviously nothing worked, until the day dawned on vaccine development for prevention of the disease. In the mid 1950s, two scientists, Jonas Salk and Albert Sabin, developed the polio vaccine.
Salk developed the inactivated poliovirus vaccine (IPV), consisting of an injected dose of killed poliovirus; Sabin developed an oral polio vaccine (OPV) using live but weakened (attenuated) virus.
Both vaccines have their advantages and fallbacks, but IPV alone has been extremely successful in eradicating poliovirus in developed countries. OPV, used in developing countries, has also proven effective in inducing protection against poliovirus, although some children may fail to develop immunity.
Sequential administration of OPV and IPV has led to almost complete eradication of this once dreadful disease.
In January this year, Sindh Chief Minister, Syed Murad Ali Shah admitted that eradicating the poliovirus was a major challenge for his government.
The question is why repeated polio campaigns have resulted in poor routine immunisation drives.
If one examines the results of the Sindh immunisation campaign launched in September and December 2016, the target was set at 2.2 million children in Karachi and 6.1m in the rural areas of the province.
But in the city, around 2.6pc of all children were unavailable at the time of immunisation, while parents of 1.7pc refused the vaccine.
Several mitigating factors have created serious inequities in immunisation coverage countrywide. Because polio eradication is mistakenly seen as the responsibility of the Expanded Program on Immunisation (EPI), polio campaigns are perceived as health department initiatives.
However, given an inadequate health infrastructure and service delivery system, and lack of inter and intra provincial collaboration and coordination within various health programs, it is not surprisingly, then, that a low uptake of vaccinations among children less than five years age has been consistently recorded.
Possibilities of using multiple polio campaigns to push forward the routine agenda have not been adequately explored.